TargetMol

Pioglitazone

Product Code:
 
TAR-T0214
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0214-5mg5mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0214-10mg10mg£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0214-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0214-25mg25mg£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0214-50mg50mg£149.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0214-100mg100mg£185.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0214-500mg500mg£353.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Pioglitazone is an insulin sensitizing agent and thiazolidinedione that is indicated for the treatment of type 2 diabetes. Pioglitazone has been linked to rare instances of acute liver injury.
CAS:
111025-46-8
Formula:
C19H20N2O3S
Molecular Weight:
356.44
Pathway:
DNA Damage/DNA Repair; Cell Cycle/Checkpoint; Metabolism; Apoptosis
Purity:
0.9818
SMILES:
CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1
Target:
Ferroptosis; PPAR

References

1. Jaakkola T, et al. Basic Clin Pharmacol Toxicol,2006, 99(1), 44-51. 2. Shiomi T, et al. Circulation,2002, 106(24), 3126-3132. 3. Dehmer T, et al. J Neurochem,2004, 88(2), 494-501. 4. Breidert T, et al. J Neurochem,2002, 82(3), 615-624. 5. Heneka MT, et al. Brain,2005, 128(Pt 6), 1442-1453. 6. Fang J, Zhang P, Wang Q, et al. Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer's Disease[J]. medRxiv. 2020, 12(2): 025032.